MOHAMED HEGAZY to Disease Progression
This is a "connection" page, showing publications MOHAMED HEGAZY has written about Disease Progression.
Connection Strength
0.071
-
Long-term remission and monocyclic course in Still's disease patients starting canakinumab early: data from the international AIDA network registry. Semin Arthritis Rheum. 2026 Oct; 80:153030.
Score: 0.038
-
The Systemic Score May Identify Life-Threatening Evolution in Still Disease: Data from the GIRRCS AOSD-Study Group and the AIDA Network Still Disease Registry. Arthritis Rheumatol. 2024 Jul; 76(7):1141-1152.
Score: 0.033